New more sensitive diagnostics protect transplanted kidney
With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...
News
News | May 25, 2020
Stockholm, 26 may 2020
Devyser welcomes Torbjörn Andersson as Chief Commercial Officer in charge of global sales and marketing of Devyser’s genetic tests. Torbjörn has extensive experience in building and leading international sales organisations and distributor networks in the life science industry. He joins us most recently from Biotage AB where he was the Head of EMEA Commercial Operations.
"I am excited to take on this challenge with Devyser, a growing company with a strong product portfolio and huge potential in a very interesting industry. The rapid advancements of DNA sequencing technology has opened up brand new opportunities for highly precise diagnostics. It is inspiring to be able to offer physicians the ability to personalize treatments of cancer and other serious genetic diseases using Devyser’s tests"
says Torbjörn Andersson.
As CCO, Torbjörn will lead and develop Devyser’s global sales and marketing organization and will be part of Devyser’s management team.
"Torbjörn’s solid experience in developing international sales organizations and implementing sales strategies add valuable strength as Devyser continues to expand on existing and new markets globally"
says Ulf Klangby, CEO Devyser.
With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...
Read More
Devyser, the pioneering leader in diagnostic solutions, launches today its first IVDR-certified...
Read More
“Further strong organic growth was reported for the year and quarter. Efforts to build an...
Read More
We are pleased to welcome Vertitas Corporation as a new distributor of the Devyser portfolio for...
Read More